Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05676450
NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
Sponsor: M.D. Anderson Cancer Center
View on ClinicalTrials.gov
Summary
To test the feasibility of collecting cell-free DNA (cfDNA) samples from DLBCL patients before and after treatment. cfDNA is DNA traveling in your blood outside of a cell and is easily collected from blood samples drawn using the vein puncture method.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
517
Start Date
2023-02-23
Completion Date
2026-08-31
Last Updated
2025-10-31
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
cell-free DNA
Given by IV (vein)
Locations (2)
MD Anderson Cancer Center
Houston, Texas, United States
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio
San Antonio, Texas, United States